Showing results (41-50 of 379) with videos related to

Sort By:
Pageof 38
Plos One|September 13, 2017
Comparative effectiveness and tolerance of immunosuppressive treatments for idiopathic membranous nephropathy: A network meta-analysisSong Ren, Ying Wang, Li Xian, et al.
Diabetes Care|September 13, 2013
Linagliptin lowers albuminuria on top of recommended standard treatment in patients with type 2 diabetes and renal dysfunctionPer-Henrik Groop, Mark E Cooper, Vlado Perkovic, et al.
JAMA|July 12, 2017
Association of Positive Airway Pressure With Cardiovascular Events and Death in Adults With Sleep Apnea: A Systematic Review and Meta-analysisJie Yu, Zien Zhou, R Doug McEvoy, et al.
BMJ Global Health|December 5, 2019
Inequities in the global representation of sites participating in large, multicentre dialysis trials: a systematic reviewBrendan Smyth, Konlawij Trongtrakul, Anna Haber, et al.
The New England Journal of Medicine|May 13, 2026
Telitacicept for IgA Nephropathy - Interim Analysis of a Phase 3 TrialJicheng Lv, Lijun Liu, Wenxiang Wang, et al.
The Cochrane Database of Systematic Reviews|April 17, 2009
HMG CoA reductase inhibitors (statins) for dialysis patientsSankar D Navaneethan, Sagar U Nigwekar, Vlado Perkovic, et al.
The Cochrane Database of Systematic Reviews|December 14, 2012
Antihypertensive agents for preventing diabetic kidney diseaseJicheng Lv, Vlado Perkovic, Celine V Foote, et al.
Kidney International Reports|October 21, 2024
Correlation of Urinary Soluble CD163 Levels With Disease Activity and Treatment Response in IgA NephropathyJingyi Li, Jicheng Lv, Muh Goet Wong, et al.
The Cochrane Database of Systematic Reviews|October 19, 2012
Antioxidants for chronic kidney diseaseMin Jun, Vinod Venkataraman, Mona Razavian, et al.
Australian Family Physician|September 12, 2013
ACEIs for cardiovascular risk reduction--have we taken our eye off the ball?Andrew Sindone, Jonathan Erlich, Vlado Perkovic, et al.
Pageof 38